Brian Salisbury

1.0k total citations
22 papers, 863 citations indexed

About

Brian Salisbury is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Brian Salisbury has authored 22 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Brian Salisbury's work include Cholesterol and Lipid Metabolism (6 papers), Cancer, Lipids, and Metabolism (3 papers) and Receptor Mechanisms and Signaling (3 papers). Brian Salisbury is often cited by papers focused on Cholesterol and Lipid Metabolism (6 papers), Cancer, Lipids, and Metabolism (3 papers) and Receptor Mechanisms and Signaling (3 papers). Brian Salisbury collaborates with scholars based in United States, Bulgaria and United Kingdom. Brian Salisbury's co-authors include William D. Wagner, D J Falcone, C R Minick, Robert E. Burrier, Eric M. Parker, Deborra Mullins, Harry R. Davis, John W. Clader, Joyce Hwa and Ambikaipakan Balasubramaniam and has published in prestigious journals such as Journal of Biological Chemistry, CHEST Journal and Journal of Medicinal Chemistry.

In The Last Decade

Brian Salisbury

21 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Salisbury United States 12 336 206 186 165 158 22 863
Kim Masuda United States 15 621 1.8× 237 1.2× 229 1.2× 133 0.8× 92 0.6× 17 1.4k
Armand B. Cognetta United States 15 728 2.2× 107 0.5× 171 0.9× 324 2.0× 138 0.9× 15 1.2k
Lee‐Ho Wang United States 15 725 2.2× 226 1.1× 103 0.6× 57 0.3× 55 0.3× 26 1.6k
Nieves Rodríguez‐Henche Spain 19 497 1.5× 430 2.1× 180 1.0× 37 0.2× 28 0.2× 31 1.1k
Eugene N. Bush United States 17 624 1.9× 128 0.6× 57 0.3× 122 0.7× 66 0.4× 43 1.1k
George A. Keesler United States 15 652 1.9× 55 0.3× 202 1.1× 24 0.1× 165 1.0× 18 1.1k
Shiro Takekawa Japan 15 383 1.1× 170 0.8× 180 1.0× 80 0.5× 35 0.2× 28 818
G Guillemette Canada 21 1.1k 3.1× 295 1.4× 131 0.7× 42 0.3× 218 1.4× 49 1.4k
Andrew D. Gribble United Kingdom 14 362 1.1× 177 0.9× 71 0.4× 88 0.5× 18 0.1× 20 674
S. M. Doel United Kingdom 12 591 1.8× 150 0.7× 213 1.1× 32 0.2× 24 0.2× 15 1.0k

Countries citing papers authored by Brian Salisbury

Since Specialization
Citations

This map shows the geographic impact of Brian Salisbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Salisbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Salisbury more than expected).

Fields of papers citing papers by Brian Salisbury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Salisbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Salisbury. The network helps show where Brian Salisbury may publish in the future.

Co-authorship network of co-authors of Brian Salisbury

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Salisbury. A scholar is included among the top collaborators of Brian Salisbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Salisbury. Brian Salisbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chapman, Richard W., Aidan K. Curran, Brian Salisbury, et al.. (2010). Effect of mometasone furoate (MF)/formoterol fumarate (F) combination (MF/F) on late-phase responses in allergen-challenged Brown Norway rats. Pulmonary Pharmacology & Therapeutics. 24(1). 67–73. 9 indexed citations
2.
Mingo, Garfield G., Michel R. Corboz, Brian Salisbury, et al.. (2010). Alpha-2c-Adrenergic Receptors Contribute to Basal Nasal Patency in the Anesthetized Cat. Pharmacology. 85(5). 259–263. 4 indexed citations
3.
Salisbury, Brian, et al.. (2007). Inducible expression and pharmacological characterization of the mouse metabotropic glutamate 5b receptor. European Journal of Pharmacology. 579(1-3). 34–39. 1 indexed citations
4.
Salisbury, Brian, et al.. (2006). JTRS Infrastructure Architecture and Standards. 1. 1–5. 12 indexed citations
5.
Kurowski, Stan, et al.. (2001). Activation of central melanocortin receptors by MT‐II increases cavernosal pressure in rabbits by the neuronal release of NO. British Journal of Pharmacology. 134(8). 1705–1710. 20 indexed citations
6.
Parker, Eric M., Ambikaipakan Balasubramaniam, M. Guzzi, et al.. (2000). [D-Trp34] neuropeptide Y is a potent and selective neuropeptide Y Y5 receptor agonist with dramatic effects on food intake☆. Peptides. 21(3). 393–399. 70 indexed citations
7.
Hwa, Joyce, Patricia A.M. Williams, Lorraine Ghibaudi, et al.. (1999). Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 277(5). R1428–R1434. 89 indexed citations
8.
Parker, Eric M., Ambikaipakan Balasubramaniam, Robert E. Burrier, et al.. (1998). GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. European Journal of Pharmacology. 349(1). 97–105. 98 indexed citations
9.
Vaccaro, Wayne, Johannes Berger, Robert E. Burrier, et al.. (1996). ChemInform Abstract: Inhibitors of Acyl CoA: Cholesterol Acyltransferase (ACAT).. ChemInform. 27(31). 4 indexed citations
10.
Vaccaro, Wayne, Joel G. Berger, Robert E. Burrier, et al.. (1996). Inhibitors of Acyl CoA:Cholesterol Acyltransferase. Journal of Medicinal Chemistry. 39(8). 1704–1719. 39 indexed citations
11.
Clader, John W., Duane A. Burnett, Mary Ann Caplen, et al.. (1996). 2-Azetidinone Cholesterol Absorption Inhibitors:  Structure−Activity Relationships on the Heterocyclic Nucleus. Journal of Medicinal Chemistry. 39(19). 3684–3693. 105 indexed citations
12.
Clader, John W., Joel G. Berger, Robert E. Burrier, et al.. (1995). Substituted (1,2-Diarylethyl)amide Acyl-CoA:Cholesterol Acyltransferase Inhibitors: Effect of Polar Groups on in Vitro and in Vivo Activity. Journal of Medicinal Chemistry. 38(10). 1600–1607. 22 indexed citations
13.
Salisbury, Brian, Harry R. Davis, Robert E. Burrier, et al.. (1995). Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis. 115(1). 45–63. 94 indexed citations
14.
Dugar, Sundeep, Harry R. Davis, Robert E. Burrier, & Brian Salisbury. (1995). Amides of piperidine, morpholine and piperazine substituted 1-phenylethylamines: Inhibitors of acylCoA:cholesterol acyltransferase (ACAT) activity in vitro and in vivo. Bioorganic & Medicinal Chemistry. 3(9). 1231–1236. 2 indexed citations
15.
Davis, Harry R., R.W. Watkins, Brian Salisbury, et al.. (1994). Effect of the cholesterol absorption inhibitor SCH48461 in combination with the HMG-CoA reductase inhibitor lovastatin in rabbits, dogs and rhesus monkeys. Atherosclerosis. 109(1-2). 162–163. 9 indexed citations
16.
Campbell, James P. & Brian Salisbury. (1990). Congenital tracheoesophageal fistula associated with carcinoma of the lung in an adult. The Annals of Thoracic Surgery. 50(6). 978–979. 2 indexed citations
17.
Salisbury, Brian, D J Falcone, & C R Minick. (1985). Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages.. PubMed. 120(1). 6–11. 112 indexed citations
18.
Salisbury, Brian & William D. Wagner. (1981). Isolation and preliminary characterization of proteoglycans dissociatively extracted from human aorta.. Journal of Biological Chemistry. 256(15). 8050–8057. 120 indexed citations
19.
Salisbury, Brian, et al.. (1974). Baygon-Induced Pulmonary Edema. CHEST Journal. 65(4). 455–457. 3 indexed citations
20.
Salisbury, Brian, et al.. (1972). Pleural Effusion: Unusual Presentation of Prostatic Cancer. CHEST Journal. 61(7). 686–689. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kim Masuda Breakdown of academic impact, for papers by Armand B. Cognetta Breakdown of academic impact, for papers by Lee‐Ho Wang Breakdown of academic impact, for papers by Nieves Rodríguez‐Henche Breakdown of academic impact, for papers by Eugene N. Bush Breakdown of academic impact, for papers by George A. Keesler Breakdown of academic impact, for papers by Shiro Takekawa Breakdown of academic impact, for papers by G Guillemette Breakdown of academic impact, for papers by Andrew D. Gribble Breakdown of academic impact, for papers by S. M. Doel
Rankless by CCL
2026